Arcus Biosciences, Inc. — Director's Dealing 2018

Mar 14, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2018-03-14

Reporting Person: Chan Steven (See Remarks)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25252	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.23	2027-04-23	Common Stock (25253)		Direct
Stock Option (right to buy)	$5.39	2028-01-03	Common Stock (36615)		Direct

Footnotes

F1: The option is exercisable in 48 equal monthly installments after April 24, 2017 provided the reporting person remains in continuous service on each vesting date; the option may also be exercised early subject to Issuer's right of repurchase.

F2: The option is exercisable in 48 equal monthly installments after January 1, 2018 provided the reporting person remains in continuous service on each vesting date; the option may also be exercised early subject to Issuer's right of repurchase.